Description: CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the sub-field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, the cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was founded in 1994 and is headquartered in Lund, Sweden.
Home Page: www.cellavision.com
Mobilvägen 12
Lund,
223 62
Sweden
Phone:
46 4 64 60 16 00
Officers
| Name | Title |
|---|---|
| Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D. | Founder & Director |
| Mr. Simon Ostergaard | CEO & Pres |
| Mr. Peter Wilson | VP of Global Marketing |
| Mr. Yve van Thorenburg | Acting VP of Global Sales & Director of APAC of Global Sales |
| Mr. Urban Strindlov | VP of Global Sales |
| Nina Wallander | VP of HR |
| Mr. Magnus Blixt | Exec. Officer |
| Mr. Julien Veyssy | Managing Director of RAL Diagnostics |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 32.7869 |
|---|---|
| Trailing PE: | 44.92 |
| Price-to-Book MRQ: | 9.1351 |
| Price-to-Sales TTM: | 8.5001 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 234 |